| Document |
Document Title |
|
JPS5938239B2 |
|
|
JPS58194898A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPS5830320B2 |
Steroids of the formula WHEREIN X is a hydrogen atom, a halogen atom or methyl; Y is a hydrogen atom or a halogen atom; Z is carbonyl, beta -acyloxymethylene or, when Y is a hydrogen atom, also methylene; R1 is a hydrogen atom or methyl;...
|
|
JPS5750800B2 |
The Specification describes compounds of the general formula WHEREIN X represents a hydrogen, chlorine or fluorine atom; R1 represents a beta -hydroxy group, an oxo group or (when X is a chlorine atom) a beta -chlorine atom; R2 represent...
|
|
JPS57131000A |
Compounds of the formula wherein Q is O or S; R2 is hydrogen or methyl; R6 is hydrogen, fluorine or methyl; either R9 is hydrogen, fluorine or chlorine, R11 is beta -chlorine, beta -hydroxyl or oxo, and the 9,11-bond is a single bond, or...
|
|
JPS5611720B1 |
1384372 Derivatives of 17α-hydroxy-androst- 4 - ene - 17# - carboxylic acid GLAXO LABORATORIES Ltd 20 Jan 1972 [20 Jan 1971] 2787/71 Heading C2U [Also in Division A5] Novel steroids of the formulµ wherein (a) X is H, Cl or F; R 1 is #-...
|
|
JPS55149300A |
NEW MATERIAL:The titled compound of formula I (R is lower alkoxy group; R1 is H, lower alkyl, or alkoxycarbonyl group; R2 is H or alkoxycarbonyl group; R3 and R4 are H, halogen, acetyl, alkoxycarbonyl, or nitrile group; R2 and R3 may for...
|
|
JPS5441590B2 |
|
|
JPS54148769A |
The present disclosure is concerned with 9 alpha -chloro-17-(m-iodobenzyloxy) steroids and a process for their manufacture. The subject compounds are useful as intermediates in the synthesis of pharmacologically-active substances and hav...
|
|
JPS54145648A |
The novel compound according to Claim 1 has a high local anti-inflammatory action, but only relatively weak systemic actions it can therefore be used for the local treatment of inflammations with a minimum risk of undesired systemic side...
|
|
JPS54141757A |
4-Halo-etianic acids and derivations of the formula: wherein X<1> is fluoro or chloro; X<2> is fluoro, chloro or hydrogen; X<3> is fluoro, chloro, bromo or hydrogen; X<4> is =C=O or of may be when X<3> is chloro; R is hydrogen, alkyl of ...
|
|
JPS54135761A |
17 beta -Thiocarboxylic acid esters of 4-halo-3-oxoandrost-4-enes of the formula: wherein X<1> is fluoro, chloro or bromo; X<2> is fluoro, chloro or hydrogen; X<3> is fluoro, chloro, bromo or hydrogen; X<4> is =C=O or or may also be when...
|
|
JPS5473765A |
Disclosed are novel 6-oxygenated-3,20-dioxo-pregnane derivatives of the general formula I and specified 1,2-dihydroderivatives thereof. wherein Z represents specified acylgroups. The other substituents of formula I include those comm...
|
|
JPS5344463B2 |
A method for lowering elevated serum lipid concentrations comprising administering a composition containing, as the active ingredient, a 3 beta -substituted-16 alpha -cyanopreg-5-en-20-one wherein the substituent at the 3 beta -position ...
|
|
JPS5330706B1 |
|
|
JPS52128363A |
The present invention provides a novel process for the manufacture of 17- and 17a-carboxylic acids of the androstane and D-homo-androstane series respectively, of the following partial formula of the ring D (I) wherein R represents a hyd...
|
|
JPS5297956A |
|
|
JPS5285159A |
Pregnanes and androstanes are described which essentially possess a 3.alpha.-hydroxy group, a S.alpha.-hydrogen atom or a 4,5- or 5,6-double bond, a 17.alpha.-hydrogen atom and an 11.beta.-aminoester group. Other optional substituents or...
|
|
JPS5130065B2 |
|
|
JPS5148649A |
Steroids with antiinflammatory activity and the formula I in which R' is methyl, ethyl, n-propyl or isopropyl; R'' is methyl, chloromethyl, fluoromethyl, bromomethyl, iodomethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl or 2-iodoethyl;...
|
|
JPS5148648A |
The specification describes new anti-inflammatory steroids having the formula WHEREIN R1 represents a C1-4 alkyl or halo- C1-4 alkyl group, R2 represents a methyl, ethyl, n-propyl or iso-propyl group (an ethyl group being especially pref...
|
|
JPS50123655A |
|
|
JPS5032158A |
1478679 Electrolytic reduction of #1,3,5(10)- to #2'5(10)-steroids SCHERING AG 17 July 1974 [18 July 1973] 31660/74 Heading C2U [Also in Division C7] #2'5(10)-Steroids containing an etherified hydroxy group in the 3-position are prepared...
|
|
JPS4949950A |
|
|
JPS4948652A |
1436324 21-Substituted 3α-hydroxy-pregnane compounds GLAXO LABORATORIES Ltd 11 May 1973 [12 May 1972] 22489/72 Heading C2U Novel steroids of the pregnane or 19- norpregnane series possess essentially a 3α-hydroxy group, a 5α-H atom or...
|
|
JPS4838702B1 |
Compounds of general formula (I) R = H or Me R1= H or hal, OH, Oalkyl or Oacyl R2= H or hal R4= OH, O acyl or O alkyl R6= H, hal or lower alkyl and R3 = a 3-keto A4, 3-keto-DELTA4,6, 3keto-DELTA1,4 3-keto-DELTA1,4,6, 3-acyloxy-DELTA3,5-,...
|
